Rappaport Reiches Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Rappaport Reiches Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$283K	Buy	568 +14	+3%	+$7.58K	0.07%	93
2024 Q4	$288K	Sell	554 -2	-0.4%	-$1.1K	0.07%	82
2024 Q3	$344K	Buy	556 +2	+0.4%	+$1.18K	0.09%	76
2024 Q2	$306K	Buy	554 +10	+2%	+$5.73K	0.09%	73
2024 Q1	$316K	Buy	544 +1	+0.2%	+$561	0.1%	80
2023 Q4	$288K	Buy	543 +129	+31%	+$62.4K	0.11%	62
2023 Q3	$210K	Buy	414 +1	+0.2%	+$533	0.09%	70
2023 Q2	$215K	Hold	413	–	–	0.09%	73
2023 Q1	$238K	Hold	413	–	–	0.11%	71
2022 Q4	$227K	Buy	413 +1	+0.2%	+$530	0.11%	68
2022 Q3	$209K	Hold	412	–	–	0.11%	68
2022 Q2	$224K	Buy	+412	New	+$227K	0.11%	70

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Rappaport Reiches Capital Management's TMO Position: Q1 2025 in Review

Rappaport Reiches Capital Management increased its Thermo Fisher Scientific (TMO) stake by 2.5% in Q1 2025, buying an estimated $7.58K and bringing the position to 568 shares worth $283K. The position accounts for 0.07% of the portfolio, ranked #93.

Rappaport Reiches Capital Management first reported a position in TMO in Q2 2022 and has held it in 12 quarters since. The position peaked at $344K in Q3 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

Rappaport Reiches Capital Management held 568 shares of Thermo Fisher Scientific worth $283K as of Q1 2025.
Rappaport Reiches Capital Management bought 14 Thermo Fisher Scientific shares in Q1 2025, an estimated $7.58K.
Thermo Fisher Scientific made up 0.07% of Rappaport Reiches Capital Management's portfolio in Q1 2025, its #93 holding.
Rappaport Reiches Capital Management first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 12 quarters since.
Rappaport Reiches Capital Management's Thermo Fisher Scientific position peaked at $344K in Q3 2024.
2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Rappaport Reiches Capital Management's 13F filing for Q1 2025, filed 22 Apr 2025.